Denice Torres's most recent trade in Celldex Therapeutics Inc. was a trade of 33,000 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celldex Therapeutics Inc. | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 33,000 | 33,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| 2seventy bio Inc | Denice M. Torres | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 May 2025 | 24,100 | 0 | - | - | Stock Options (Right to buy) | |
| 2seventy bio Inc | Denice M. Torres | Director | 13 May 2025 | 19,510 | 0 | - | - | Common Stock | ||
| 2seventy bio Inc | Denice M. Torres | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 May 2025 | 12,050 | 19,510 | - | - | Common Stock | |
| Glaukos Corporation | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 3,149 | 3,149 | - | - | Stock Option (Right to Buy) | |
| Glaukos Corporation | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 2,108 | 21,711 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 461 | 19,603 (0%) | 0% | 0 | Common Stock | |
| 2seventy bio Inc | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 24,100 | 24,100 | - | - | Stock Options (Right to buy) | |
| 2seventy bio Inc | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 12,050 | 31,560 | - | 0 | Common Stock | |
| Glaukos Corporation | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 1,716 | 19,142 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 1,246 | 1,246 | - | - | Stock Option (Right to Buy) | |
| Glaukos Corporation | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 895 | 17,426 (0%) | 0% | 0 | Common Stock | |
| Karuna Therapeutics Inc | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 1,904 | 1,904 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 990 | 990 (0%) | 0% | 0 | Common Stock | |
| 2seventy bio Inc | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 16,900 | 16,900 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 8,400 | 19,510 | - | 0 | Common Stock | |
| Glaukos Corporation | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,230 | 16,531 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 1,572 | 13,301 (0%) | 0% | 0 | Common Stock | |
| Karuna Therapeutics Inc | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 5,000 | 5,000 | - | - | Option (right to buy) | |
| 2seventy bio Inc | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,900 | 16,900 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 8,200 | 11,110 | - | 0 | Common Stock | |
| Glaukos Corporation | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 4,364 | 11,729 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 1,455 | 7,365 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Denice M. Torres | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 5,000 | 0 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Denice M. Torres | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 4,500 | 4,430 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 3,219 | 3,219 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 2,002 | 2,910 | - | 0 | Common Stock | |
| Bluebird bio Inc | Denice M. Torres | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 1,476 | 2,726 (0%) | 0% | 0 | Common Stock | |
| 2seventy bio Inc | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 1,476 | 1,476 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 492 | 492 | - | 0 | Common Stock | |
| Karuna Therapeutics Inc | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 8,500 | 8,500 | - | - | Option (right to buy) | |
| Bluebird bio Inc | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 3,109 | 5,859 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 2,382 | 5,910 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 3,079 | 3,079 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 449 | 3,528 (0%) | 0% | 0 | Common Stock | |
| Karuna Therapeutics Inc | Denice Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2020 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Bluebird bio Inc | Denice Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2020 | 4,500 | 4,500 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Denice Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2020 | 2,250 | 2,750 (0%) | 0% | 0 | Common Stock |